Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Improper Marketing and Advertising of Risperdal and Invega – Multistate Settlement

Johnson & Johnson and its subsidiary Janssen Pharmaceuticals reached a $181 million settlement with 37 states and the District of Columbia to resolve charges of improper marketing and advertising of the antipsychotic drugs Risperdal and Invega. The states alleged that from 1998 through at least 2004 Janssen engaged in deceptive and misleading practices when it marketed Risperdal, Risperdal Consta, Risperdal M-Tab, and Invega for off-label uses, and that Janssen concealed and misrepresented information regarding the side effects and efficacy of Risperdal.

Misconduct Type
Health
Enforcement Agency
State/Local
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Settlement Announcement
8/30/2012
Contractors Involved Penalty
Total
Johnson & Johnson $181,000,000
Further Information Released
New York AG Press Release 8/30/2012

Federal Contractor Misconduct Database